Crinetics Pharmaceuticals, Inc. (CRNX) Net income 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$465.3MFY2025 · since FY2016: -$6.0M → -$465.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$465.3M | -55.9% |
| FY2024 | -$298.4M | -39.1% |
| FY2023 | -$214.5M | -30.9% |
| FY2022 | -$163.9M | -52.3% |
| FY2021 | -$107.6M | -45.8% |
| FY2020 | -$73.8M | -46.4% |
| FY2019 | -$50.4M | -86.0% |
| FY2018 | -$27.1M | -196.1% |
| FY2017 | -$9.2M | -52.1% |
| FY2016 | -$6.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice